Integrating pharmacy-based prevention & treatment of opioid & other substance use disorders: a survey of pharmacists & stakeholders. 9/1/2020-7/31/2022. N01DA-19-2250. Task order 75N95020F00005(TO16).
Ended Awarded Last action
- Contract number
- 75N95020F00005
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $347,989
Award facts
- Opportunity
-
- 75N95020F00005 Solicitation number
- Contract value 100% obligated
- $347,989.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,027 | |
| Change Order | $0 | |
| Original award | $350,016 |
About this award
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to The Emmes Company LLC, a for-profit limited liability company. The contract is for a two-year period from September 1, 2020, to July 31, 2022, with a ceiling value of $347,989.16.
The purpose of the contract is to conduct a survey of pharmacists and other stakeholders to assess the integration of pharmacy-based prevention and treatment of opioid and other substance use disorders. This contract falls under NIDA's "DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER" major program. The Emmes Company LLC has extensive experience providing clinical research support services to federal agencies, particularly within the National Institutes of Health.
This contract was not set aside for any specific business category. The Emmes Company LLC has been awarded several significant Indefinite Delivery Vehicle (IDV) contracts with federal agencies, demonstrating its capability to serve as a critical research support partner across complex scientific research programs.
Quick answers
Who was awarded contract 75N95020F00005?
75N95020F00005 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 1, 2020.
How much is contract 75N95020F00005 worth?
The government has obligated $347,989 on 75N95020F00005.
Is contract 75N95020F00005 an order under another contract?
Yes. 75N95020F00005 is a delivery order under 75N95019D00013, an indefinite delivery contract.
Was contract 75N95020F00005 competed?
The extent of competition for 75N95020F00005 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award